The 4.5-Hour Time Window for Intravenous Thrombolysis With Intravenous Tissue-Type Plasminogen Activator Is Not Firmly Established

被引:8
作者
Wechsler, Lawrence R. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA
关键词
tissue plasminogen activator; stroke; ACUTE ISCHEMIC-STROKE; RANDOMIZED CONTROLLED-TRIAL; ALTEPLASE;
D O I
10.1161/STROKEAHA.113.002701
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:914 / 915
页数:2
相关论文
共 5 条
[1]   Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaernic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial [J].
Bluhmki, Erich ;
Chamorro, Angel ;
Davalos, Antoni ;
Machnig, Thomas ;
Sauce, Christophe ;
Wahlgren, Nils ;
Wardlaw, Joanna ;
Hacke, Werner .
LANCET NEUROLOGY, 2009, 8 (12) :1095-1102
[2]   Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset - The ATLANTIS study: A randomized controlled trial [J].
Clark, WM ;
Wissman, S ;
Albers, GW ;
Jhamandas, JH ;
Madden, KP ;
Hamilton, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2019-2026
[3]   Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke [J].
Hacke, Werner ;
Kaste, Markku ;
Bluhmki, Erich ;
Brozman, Miroslav ;
Davalos, Antoni ;
Guidetti, Donata ;
Larrue, Vincent ;
Lees, Kennedy R. ;
Medeghri, Zakaria ;
Machnig, Thomas ;
Schneider, Dietmar ;
von Kummer, Ruediger ;
Wahlgren, Nils ;
Toni, Danilo .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) :1317-1329
[4]   The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial [J].
Sandercock, Peter ;
Wardlaw, Joanna M. ;
Lindley, Richard I. ;
Dennis, Martin ;
Cohen, Geoff ;
Murray, Gordon ;
Innes, Karen ;
Venables, Graham ;
Czlonkowska, Anna ;
Kobayashi, Adam ;
Ricci, Stefano ;
Murray, Veronica ;
Berge, Eivind ;
Slot, Karsten Bruins ;
Hankey, Graeme J. ;
Correia, Manuel ;
Peeters, Andre ;
Matz, Karl ;
Lyrer, Phillippe ;
Gubitz, Gord ;
Phillips, Stephen J. ;
Arauz, Antonio ;
Baigent, Colin ;
Chadwick, David ;
Tyrrell, Pippa ;
Lowe, Gordon ;
Farrall, Andrew ;
von Kummer, Rudiger ;
Cala, Lesley ;
von Heijne, Anders ;
Morris, Zoe ;
Adami, Alessandro ;
Potter, Gillian ;
Brady, Nick ;
Collins, Rory ;
Bath, Philip ;
van Gijn, Jan ;
Gray, Richard ;
Hart, Robert ;
Yusuf, Salim ;
Muir, Keith ;
Brainin, Michael ;
Engelter, Stefan ;
Terent, Andreas ;
Norrving, Bo ;
Wester, Per ;
Clark, Alison ;
Perry, David ;
Soosay, Vera ;
Buchanan, David .
LANCET, 2012, 379 (9834) :2352-2363
[5]   Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis [J].
Wardlaw, Joanna M. ;
Murray, Veronica ;
Berge, Eivind ;
del Zoppo, Gregory ;
Sandercock, Peter ;
Lindley, Richard L. ;
Cohen, Geoff .
LANCET, 2012, 379 (9834) :2364-2372